Back to Search
DEAN ADELMAN, DO
DO
Family Medicine Physician
NPI: 1962465518Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
OS17044(FL)291913(NY)
Research & Publications (19)
Constructivist strategies in online distance education in nursing.
PMID 19260397·J Nurs Educ·2009
6-review
Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy.
PMID 18269927·J Allergy Clin Immunol·2008
4-observational
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.
PMID 17938863·Invest New Drugs·2008
3-trial
HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature.
PMID 16824955·Dev Cell·2006
7-preclinical
Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation.
PMID 16287860·Mol Cell Biol·2005
7-preclinical
Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.
PMID 15478383·Ann Allergy Asthma Immunol·2004
3-trial
The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid.
PMID 15240514·Clin Cancer Res·2004
8-other
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results.
PMID 12939212·Circulation·2003
3-trial
Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium.
PMID 12410519·Catheter Cardiovasc Interv·2002
6-review
Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt.
PMID 11381139·Proc Natl Acad Sci U S A·2001
7-preclinical
Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cells.
PMID 11348871·Arterioscler Thromb Vasc Biol·2001
7-preclinical
Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data.
PMID 11157039·J Clin Oncol·2001
3-trial
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.
PMID 11157038·J Clin Oncol·2001
3-trial
HIF-1 is essential for multilineage hematopoiesis in the embryo.
PMID 10849668·Adv Exp Med Biol·2000
7-preclinical
Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses.
PMID 11124810·Genes Dev·2000
7-preclinical
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.
PMID 11163212·Mol Cell·2000
7-preclinical
Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin).
PMID 11067782·Circulation·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 260 AVENUE X
BROOKLYN, NY 11223 - Phone
- (718) 522-3399
Quick Facts
- NPI
- 1962465518
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile